Dave Keating

With fundraising down and exits up in the first quarter of 2007, US venture capital is continuing on the tail end of its current cycle. But as the NVCA’s Mark Heesen points out, the quarter’s results shows a subtle change in the psychology of the market. Dave Keating reports.

A year-end predictions survey released by the NVCA shows that though there is some optimism for future IPO performance among VCs, many will be actively looking for alternative exit strategies, including M&As by private equity firms. Dave Keating examines the results.

Frazier and Delphi Ventures’ recent exit from a medical device incubator looks more like a private equity play than your typical start-up facility support. Dave Keating reports.

NVCA president Mark Heesen says the sudden drop in US venture fundraising in Q3 may not be such a bad thing for VCs. Dave Keating reports.

GTCR will invest its ninth and largest fund using the firm’s manager-focused strategy.

The Boston-based firm has closed three significant retail transactions in the last two weeks.

Emerging markets investment firm Darby Overseas Investments has made an €8m investment in Latvian company AS Rigas Piensaimniekes.

The Boston-based firm’s new fund will make equity investments of $50m to $350m primarily in North America.

Baxter International will sell its Transfusion Therapies business to Texas Pacific Group and partner Maverick Capital.

The Los Angeles-based firm has closed one of the largest mezzanine funds ever, according to a report.